The innovative year of 2016 contributed significantly in the field of cardiology. To continue to our previous series on breakthroughs of 2016 , here we have included the FDA approved new technologies or developments in the cardiology. Bioresorbable stents: This would solve a major issue relating to cardio-surgery. It is hoped that the bioabsorbable stent would avoid or overcome the downsides of metal in the artery.
Bioabsorbable stents would avoid the loss of (and perhaps restore) normal vasomotion (ability to constrict and relax), improve persistently abnormal endothelial function, and permit vessel remodeling not possible within the metallic stent cage. The Bottom Line: Bioresorbable stents have the great potential to replace current metal stents or drug-eluting stents. However, with the current research the physicians may have to wait for next 4-5 years utilizing the full potential…
